SFX by Ex Libris Inc.

Title:	Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5
Source:	Science [0036-8075] Mavrakis, K J yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kryukov, Gregory V. "MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells." Science 351.6278 (2016): 1214-1218.
description	2.	Marjon, K. "MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis." Cell Reports 15.3 (2016): 574-587.
description	3.	Duncan, Kenneth w. "Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666." ACS medicinal chemistry letters 7.2 (2016): 162-166.
description	4.	Toyama, Erin Q. "Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress." Science 351.6270 (2016): 275-81.
description	5.	Koyama, S. "Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints." Nature Communications 7.1 (2016): 10501-10501.
description	6.	Yanling Zhao, D. "SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination." Nature 529.7584 (2015): 48-53.
description	7.	Miller, J. "Slow Growth and No Growth: Why the U.S. Economy Is Outperforming Europe and Japan." New labor forum (2015): 44-51.
description	8.	DUDASHJR, J. "Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors." Bioorganic & medicinal chemistry letters 15.21 (2005): 4790-32.
description	9.	FU, S. "Medicinal chemistry strategies targeting PRMT5 for cancer therapy." European journal of medicinal chemistry 244C (2022): 114842-114842.
description	10.	Castillo Aguilera, O. "DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge." Biomolecules 7.1 (2017): 3-.
description	11.	Song, G. "Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice." Science 350.6265 (2015).
description	12.	von Eyss, B. "A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer." Cancer cell 28.6 (2015): 743-757.
description	13.	Li, J. "Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction." Journal of molecular and cellular cardiology 86 (2015): 62-74.
description	14.	Chan Penebre, E. "A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models." Nature Chemical Biology 11.6 (2015): 432-7.
description	15.	Otera, H. "Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells." The Journal of cell biology 191.6 (2010): 1141-1158.
description	16.	Aragones, J. "Oxygen Sensors at the Crossroad of Metabolism." Cell metabolism 9.1 (2009): 11-22.
description	17.	Walter, M. "Azole derivatives as histamine H3 receptor antagonists, Part 2: C-C and C-S coupled heterocycles." Bioorganic and medicinal chemistry letters 20.19 (2010): 5883-5886.
description	18.	Kortum, S. "Thienopyrimidine-based P2Y12 platelet aggregation inhibitors." Bioorganic & medicinal chemistry letters 19.20 (2009): 5919-23.
description	19.	Devreux, V. "Divergent Strategy for the Synthesis of Î±-Aryl-Substituted Fosmidomycin Analogues." Journal of organic chemistry 72.10 (2007): 3783-9.
description	20.	Bramson, H. l. "Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis." Journal of medicinal chemistry 44.25 (2001): 4339-4358.